Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: LEUKEMIA, MYELOID, ACUTE - THERAPY , . Treffer: 19

2017

Heidenreich, S; Ziagkos, D; de Wreede, LC; van Biezen, A; Finke, J; Platzbecker, U; Niederwieser, D; Einsele, H; Bethge, W; Schleuning, M; Beelen, DW; Tischer, J; Nagler, A; Glass, B; Maertens, J; Yáñez, L; Beguin, Y; Sill, H; Scheid, C; Stelljes, M; Ganser, A; Zachée, P; Selleslag, D; de Witte, T; Robin, M; Kröger, N Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.
Biol Blood Marrow Transplant. 2017; 23(1):44-52 Doi: 10.1016/j.bbmt.2016.09.027 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Klobassa, DS; Dworzak, MN; Lanz, S; Skrabl-Baumgartner, A; Beham-Schmid, C; Cerroni, L; Haas, OA; Wlodarski, M; Salzer, U; Lackner, H; Benesch, M; Schwinger, W; Urban, C; Seidel, MG Chilblain lupus and steroid-responsive pancytopenia precede monosomy 7-linked AML as manifestation of rasopathy.
PEDIATR BLOOD CANCER. 2017; 64(12): Doi: 10.1002/pbc.26724 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2016

Lanz, S; Schwinger, W; Sovinz, P; Lackner, H; Resch, B; Urlesberger, B; Sipurzynski, S; Urban, C Successful Unrelated Stem Cell Transplantation in an Infant With Congenital Acute Myelogenous Leukemia FAB M5 Showing Massive Cutaneous Infiltrations--A Challenging Multidisciplinary Approach.
Pediatr Blood Cancer. 2016; 63(1):160-163 Doi: 10.1002/pbc.25703 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Styczynski, J; Tridello, G; Gil, L; Ljungman, P; Hoek, J; Iacobelli, S; Ward, KN; Cordonnier, C; Einsele, H; Socie, G; Milpied, N; Veelken, H; Chevallier, P; Yakoub-Agha, I; Maertens, J; Blaise, D; Cornelissen, J; Michallet, M; Daguindau, E; Petersen, E; Passweg, J; Greinix, H; Duarte, RF; Kröger, N; Dreger, P; Mohty, M; Nagler, A; Cesaro, S Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.
J Clin Oncol. 2016; 34(19):2212-2220 Doi: 10.1200/JCO.2015.64.2405
Web of Science PubMed FullText FullText_MUG

 

2015

Lang, P; Feuchtinger, T; Teltschik, HM; Schwinger, W; Schlegel, P; Pfeiffer, M; Schumm, M; Lang, AM; Lang, B; Schwarze, CP; Ebinger, M; Urban, C; Handgretinger, R Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients.
Bone Marrow Transplant. 2015; 50 Suppl 2(4):S6-10 Doi: 10.1038/bmt.2015.87 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Reinisch, A; Chan, SM; Thomas, D; Majeti, R Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells.
Semin Hematol. 2015; 52(3): 150-164. Doi: 10.1053/j.seminhematol.2015.03.008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Lang, P; Teltschik, HM; Feuchtinger, T; Müller, I; Pfeiffer, M; Schumm, M; Ebinger, M; Schwarze, CP; Gruhn, B; Schrauder, A; Albert, MH; Greil, J; Urban, C; Handgretinger, R Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.
Br J Haematol. 2014; 165(5):688-698 Doi: 10.1111/bjh.12810 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rabitsch, W; Böhm, A; Bojic, M; Schellongowski, P; Wöhrer, S; Sliwa, T; Keil, F; Worel, N; Greinix, H; Hauswirth, A; Kalhs, P; Jaeger, U; Valent, P; Sperr, WR Clofarabine/cyclophosphamide for debulking before stem cell transplantation.
Eur J Clin Invest. 2014; 44(8):775-783 Doi: 10.1111/eci.12294
Web of Science PubMed FullText FullText_MUG

 

2012

Busemann, C; Ribback, S; Zimmermann, K; Sailer, V; Kiefer, T; Schmidt, CA; Schulz, K; Steinmetz, I; Dombrowski, F; Dölken, G; Krüger, WH Toxoplasmosis after allogeneic stem cell transplantation--a single centre experience.
Ann Hematol. 2012; 91(7):1081-1089 Doi: 10.1007/s00277-012-1406-5 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Nagler, A; Labopin, M; Shimoni, A; Niederwieser, D; Mufti, GJ; Zander, AR; Arnold, R; Greinix, H; Cornelissen, JJ; Jackson, GH; Craddock, C; Bunjes, DW; Ganser, A; Russell, NH; Kyrcz-Krzemien, S; Rocha, V; Mohty, M Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant. 2012; 18(9):1422-1429 Doi: 10.1016/j.bbmt.2012.02.013 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ringdén, O; Labopin, M; Beelen, DW; Volin, L; Ehninger, G; Finke, J; Greinix, HT; Kyrcz-Krzemien, S; Bunjes, D; Brinch, L; Niederwieser, D; Arnold, R; Mohty, M; Rocha, V; Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT) Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients.
J Intern Med. 2012; 272(5):472-483 Doi: 10.1111/j.1365-2796.2012.02547.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Craddock, C; Labopin, M; Pillai, S; Finke, J; Bunjes, D; Greinix, H; Ehninger, G; Steckel, NK; Zander, AR; Schwerdtfeger, R; Buchholz, S; Kolb, HJ; Volin, L; Fauser, A; Polge, E; Schmid, C; Mohty, M; Rocha, V Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia.
Leukemia. 2011; 25(5): 808-813. Doi: 10.1038/leu.2011.13 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sill, H; Olipitz, W; Zebisch, A; Schulz, E; Wölfler, A Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
Br J Pharmacol. 2011; 162(4): 792-805. Doi: 10.1111/j.1476-5381.2010.01100.x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2008

Holler, E; Hahn, J; Andreesen, R; Rogler, G; Brenmoehl, J; Greinix, H; Dickinson, AM; Socie, G; Wolff, D; Finke, J NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters.
J Clin Oncol. 2008; 26(2): 338-339. Doi: 10.1200/JCO.2007.14.1325
Web of Science PubMed FullText FullText_MUG

 

2002

Greinix, HT DLI or second transplant.
Ann Hematol. 2002; 81 Suppl 2(5):S34-S35
Web of Science PubMed

 

2001

Keil, F; Prinz, E; Kalhs, P; Lechner, K; Moser, K; Schwarzinger, I; Jäger, U; Fonatsch, C; Worel, N; Mannhalter, C; Rabitsch, W; Loidolt, H; Schulenburg, A; Mitterbauer, M; Höcker, P; Greinix, HT Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.
Leukemia. 2001; 15(3):355-361 Doi: 10.1038/sj.leu.2402048 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2000

Greinix, HT; Loidolt, H; Rabitsch, W; Schulenburg, A; Keil, F; Mitterbauer, M; Laczika, K; Lechner, K; Dieckmann, K; Fischer, G; Jäger, U; Rosenmayr, A; Knöbl, P; Schwarzinger, I; Höcker, P; Mannhalter, C; Hinterberger, W; Haas, OA; Fonatsch, C; Kalhs, P Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia.
Ann Hematol. 2000; 79(4):206-213 Doi: 10.1007/s002770050580
Web of Science PubMed FullText FullText_MUG

 

1998

Becherer, A; Schulenburg, A; Bankl, HC; Schöfl, R; Keil, F; Reiter, E; Greinix, HT; Pikula, B; Kalhs, P Bile duct adenocarcinoma mimicking veno-occlusive disease after autologous bone marrow transplantation for acute leukaemia.
Bone Marrow Transplant. 1998; 21(12):1275-1277 Doi: 10.1038/sj.bmt.1701253 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1994

Kusec, R; Laczika, K; Knöbl, P; Friedl, J; Greinix, H; Kahls, P; Linkesch, W; Schwarzinger, I; Mitterbauer, G; Purtscher, B AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
Leukemia. 1994; 8(5):735-739
Web of Science PubMed Google Scholar

 

© Med Uni Graz Impressum